Laurent Bellon

1.0k total citations
24 papers, 667 citations indexed

About

Laurent Bellon is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Laurent Bellon has authored 24 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Infectious Diseases. Recurrent topics in Laurent Bellon's work include DNA and Nucleic Acid Chemistry (8 papers), RNA and protein synthesis mechanisms (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Laurent Bellon is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), RNA and protein synthesis mechanisms (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Laurent Bellon collaborates with scholars based in United States, France and Germany. Laurent Bellon's co-authors include Jean‐Louis Imbach, Leonid Beigelman, Lawrence M. Blatt, J. L. Barascut, F. Morvan, Robert W. Siegel, C. Cheng Kao, Jennifer A. Sandberg, Karin S. Blanchard and Yogesh S. Sanghvi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Laurent Bellon

24 papers receiving 622 citations

Peers

Laurent Bellon
I. Wayne Cheney United States
Juili Lin-Goerke United States
John Wickersham United States
Dorjbal Dorjsuren United States
Nikos Pagratis United States
J O Ojwang United States
E. Slattery United States
Zhufang Li United States
I. Wayne Cheney United States
Laurent Bellon
Citations per year, relative to Laurent Bellon Laurent Bellon (= 1×) peers I. Wayne Cheney

Countries citing papers authored by Laurent Bellon

Since Specialization
Citations

This map shows the geographic impact of Laurent Bellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Bellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Bellon more than expected).

Fields of papers citing papers by Laurent Bellon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Bellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Bellon. The network helps show where Laurent Bellon may publish in the future.

Co-authorship network of co-authors of Laurent Bellon

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Bellon. A scholar is included among the top collaborators of Laurent Bellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Bellon. Laurent Bellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smulders, M.J.M., Roeland E. Voorrips, G. Esselink, et al.. (2015). DEVELOPMENT OF THE WAGRHSNP AXIOM SNP ARRAY BASED ON SEQUENCES FROM TETRAPLOID CUT ROSES AND GARDEN ROSES. Acta Horticulturae. 177–184. 5 indexed citations
2.
Malerczyk, Claudius, Anke M. Schulte, Frank Czubayko, et al.. (2004). Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach. Gene Therapy. 12(4). 339–346. 12 indexed citations
3.
Macejak, Dennis G., Kristi Jensen, Sharon F. Jamison, et al.. (2000). Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology. 31(3). 769–776. 93 indexed citations
4.
Lee, Patrice A., Lawrence M. Blatt, Karin S. Blanchard, et al.. (2000). Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice. Hepatology. 32(3). 640–646. 38 indexed citations
5.
Sandberg, Jennifer A., Karin S. Blanchard, Laurent Bellon, et al.. (2000). Acute Toxicology and Pharmacokinetic Assessment of a Ribozyme (ANGIOZYME™) Targeting Vascular Endothelial Growth Factor Receptor mRNA in the Cynomolgus Monkey. Antisense and Nucleic Acid Drug Development. 10(3). 153–162. 29 indexed citations
6.
Bellon, Laurent, Lara Maloney, Shawn Zinnen, Jennifer A. Sandberg, & Kevin E. Johnson. (2000). Quantitative Determination of a Chemically Modified Hammerhead Ribozyme in Blood Plasma Using 96-Well Solid-Phase Extraction Coupled with High-Performance Liquid Chromatography or Capillary Gel Electrophoresis. Analytical Biochemistry. 283(2). 228–240. 10 indexed citations
7.
Bellon, Laurent. (2000). Oligoribonucleotides with 2′‐O‐(tert‐Butyldimethylsilyl) Groups. Current Protocols in Nucleic Acid Chemistry. 1(1). Unit 3.6–Unit 3.6. 34 indexed citations
8.
Sandberg, Jennifer A., Vann P. Parker, Karin S. Blanchard, et al.. (2000). Pharmacokinetics and Tolerability of an Antiangiogenic Ribozyme (ANGIOZYME™) in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(12). 1462–1469. 31 indexed citations
9.
Hansen, Mark R., Jean‐Pierre Simorre, Paul Hanson, et al.. (1999). Identification and characterization of a novel high affinity metal-binding site in the hammerhead ribozyme. RNA. 5(8). 1099–1104. 36 indexed citations
10.
Siegel, Robert W., Laurent Bellon, Leonid Beigelman, & C. Cheng Kao. (1999). Use of DNA, RNA, and Chimeric Templates by a Viral RNA-Dependent RNA Polymerase: Evolutionary Implications for the Transition from the RNA to the DNA World. Journal of Virology. 73(8). 6424–6429. 28 indexed citations
11.
Siegel, Robert W., Laurent Bellon, Leonid Beigelman, & C. Cheng Kao. (1998). Moieties in an RNA promoter specifically recognized by a viral RNA-dependent RNA polymerase. Proceedings of the National Academy of Sciences. 95(20). 11613–11618. 47 indexed citations
12.
Bellon, Laurent, et al.. (1996). An Extended Phosphate Linkage: Synthesis, Hybridization and Modeling Studies of Modified Oligonucleotides. Nucleosides and Nucleotides. 15(7-8). 1383–1395. 8 indexed citations
13.
Bellon, Laurent, Christopher T. Workman, J Scherrer, Nassim Usman, & Francine E. Wincott. (1996). Morpholino-Linked Ribozymes:  A Convergent Synthetic Approach. Journal of the American Chemical Society. 118(15). 3771–3772. 22 indexed citations
14.
Bellon, Laurent, et al.. (1995). 4′-Thio-β-D-oligoribonucleotides: Nuclease Resistance and Hydrogen Bonding Properties. Nucleosides and Nucleotides. 14(3-5). 1027–1030. 11 indexed citations
16.
Sanghvi, Yogesh S., Laurent Bellon, F. Morvan, et al.. (1995). Synthesis, Biophysical and Biological Evaluations of Novel Antisense Oligonucleosides Containing Dephosphono-Internucleosidic Linkages. Nucleosides Nucleotides & Nucleic Acids. 14(3). 1087–1090. 5 indexed citations
17.
Bellon, Laurent, et al.. (1994). A New Synthesis of Some 4′-Thio-D-ribonucleosides and Preliminary Enzymatic Evaluation. Nucleosides and Nucleotides. 13(10). 2035–2050. 27 indexed citations
19.
Bellon, Laurent, et al.. (1993). A Reinvestigation of the Synthesis of 4-Thio-Pentofuranosides for Further Nucleosidic Synthesis. Nucleosides and Nucleotides. 12(8). 847–852. 8 indexed citations
20.
Bellon, Laurent, et al.. (1992). Sugar modified oligonucleotides: Synthesis, nuclease resistance and base pairing of oligodeoxynucleotides containing 1-(4′-thio-β-d-ribofuranosyl)-thymine. Biochemical and Biophysical Research Communications. 184(2). 797–803. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026